{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:30:19Z","timestamp":1758274219686,"version":"3.37.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2014-51991R"],"award-info":[{"award-number":["SAF2014-51991R"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011596","name":"Conselleria d'Educaci\u00f3, Investigaci\u00f3, Cultura i Esport","doi-asserted-by":"publisher","award":["PROMETEO\/2019\/060"],"award-info":[{"award-number":["PROMETEO\/2019\/060"]}],"id":[{"id":"10.13039\/501100011596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["681002"],"award-info":[{"award-number":["681002"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014849","name":"Conselleria de Cultura, Educaci\u00f3n y Ciencia, Generalitat Valenciana","doi-asserted-by":"publisher","award":["acif\/2019\/145"],"award-info":[{"award-number":["acif\/2019\/145"]}],"id":[{"id":"10.13039\/501100014849","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["fi18\/00260"],"award-info":[{"award-number":["fi18\/00260"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>High-throughput pharmaco-toxicological testing frequently relies on the use of established liver-derived cell lines, such as HepG2 cells. However, these cells often display limited hepatic phenotype and features of neoplastic transformation that may bias the interpretation of the results. Alternate models based on primary cultures or differentiated pluripotent stem cells are costly to handle and difficult to implement in high-throughput screening platforms. Thus, cells without malignant traits, optimal differentiation pattern, producible in large and homogeneous amounts and with patient-specific phenotypes would be desirable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We have designed and implemented a novel and robust approach to obtain hepatocytes from individuals by direct reprogramming, which is based on a combination of a single doxycycline-inducible polycistronic vector system expressing HNF4A, HNF1A and FOXA3, introduced in human fibroblasts previously transduced with human telomerase reverse transcriptase (hTERT). These cells can be maintained in fibroblast culture media, under standard cell culture conditions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Clonal hTERT-transduced human fibroblast cell lines can be expanded at least to 110 population doublings without signs of transformation or senescence. They can be easily differentiated at any cell passage number to hepatocyte-like cells with the simple addition of doxycycline to culture media. Acquisition of a hepatocyte phenotype is achieved in just 10\u00a0days and requires a simple and non-expensive cell culture media and standard 2D culture conditions. Hepatocytes reprogrammed from low and high passage hTERT-transduced fibroblasts display very similar transcriptomic profiles, biotransformation activities and show analogous pattern behavior in toxicometabolomic studies. Results indicate that this cell model outperforms HepG2 in toxicological screening. The procedure also allows generation of hepatocyte-like cells from patients with given pathological phenotypes. In fact, we succeeded in generating hepatocyte-like cells from a patient with alpha-1 antitrypsin deficiency, which recapitulated accumulation of intracellular alpha-1 antitrypsin polymers and deregulation of unfolded protein response and inflammatory networks.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our strategy allows the generation of an unlimited source of clonal, homogeneous, non-transformed induced hepatocyte-like cells, capable of performing typical hepatic functions and suitable for pharmaco-toxicological high-throughput testing. Moreover, as far as hepatocyte-like cells derived from fibroblasts isolated from patients suffering hepatic dysfunctions, retain the disease traits, as demonstrated for alpha-1-antitrypsin deficiency, this strategy can be applied to the study of other cases of anomalous hepatocyte functionality.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-023-03311-w","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T16:03:31Z","timestamp":1681833811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A robust reprogramming strategy for generating hepatocyte-like cells usable in pharmaco-toxicological studies"],"prefix":"10.1186","volume":"14","author":[{"given":"Guillem","family":"Garcia-Llorens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Mart\u00ednez-Sena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Pareja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laia","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 V.","family":"Castell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7285-0536","authenticated-orcid":false,"given":"Roque","family":"Bort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"3311_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1517\/17425255.2.2.183","volume":"2","author":"JV Castell","year":"2006","unstructured":"Castell JV, Jover R, Mart\u00ednez-Jim\u00e9nez CP, G\u00f3mez-Lech\u00f3n MJ. Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies. Expert Opin Drug Metab Toxicol. 2006;2:183\u2013212.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3311_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","volume":"28","author":"HHJ Gerets","year":"2012","unstructured":"Gerets HHJ, Tilmant K, Gerin B, Chanteux H, Depelchin BO, Dhalluin S, et al. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol. 2012;28:69\u201387.","journal-title":"Cell Biol Toxicol"},{"key":"3311_CR3","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3109\/00498254.2012.675093","volume":"42","author":"A Burkard","year":"2012","unstructured":"Burkard A, D\u00e4hn C, Heinz S, Zutavern A, Sonntag-Buck V, Maltman D, et al. Generation of proliferating human hepatocytes using Upcyte\u00ae technology: characterisation and applications in induction and cytotoxicity assays. Xenobiotica Fate Foreign Compd Biol Syst. 2012;42:939\u201356.","journal-title":"Xenobiotica Fate Foreign Compd Biol Syst"},{"key":"3311_CR4","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jhep.2021.04.048","volume":"75","author":"M Rombaut","year":"2021","unstructured":"Rombaut M, Boeckmans J, Rodrigues RM, van Grunsven LA, Vanhaecke T, De Kock J. Direct reprogramming of somatic cells into induced hepatocytes: cracking the Enigma code. J Hepatol. 2021;75:690\u2013705.","journal-title":"J Hepatol"},{"key":"3311_CR5","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/cells11030442","volume":"11","author":"T Tricot","year":"2022","unstructured":"Tricot T, Verfaillie CM, Kumar M. Current status and challenges of human induced pluripotent stem cell-derived liver models in drug discovery. Cells. 2022;11:442.","journal-title":"Cells"},{"key":"3311_CR6","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/j.stemcr.2017.10.019","volume":"9","author":"Y Gao","year":"2017","unstructured":"Gao Y, Zhang X, Zhang L, Cen J, Ni X, Liao X, et al. Distinct gene expression and epigenetic signatures in hepatocyte-like cells produced by different strategies from the same donor. Stem Cell Rep. 2017;9:1813\u201324.","journal-title":"Stem Cell Rep"},{"key":"3311_CR7","doi-asserted-by":"publisher","first-page":"17978","DOI":"10.1038\/s41598-019-54357-x","volume":"9","author":"M Ballester","year":"2019","unstructured":"Ballester M, Sentandreu E, Luongo G, Santamaria R, Bolonio M, Alcoriza-Balaguer MI, et al. Glutamine\/glutamate metabolism rewiring in reprogrammed human hepatocyte-like cells. Sci Rep. 2019;9:17978.","journal-title":"Sci Rep"},{"key":"3311_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.stem.2014.01.003","volume":"14","author":"P Huang","year":"2014","unstructured":"Huang P, Zhang L, Gao Y, He Z, Yao D, Wu Z, et al. Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell. 2014;14:370\u201384.","journal-title":"Cell Stem Cell"},{"key":"3311_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s13287-019-1416-5","volume":"10","author":"M Ballester","year":"2019","unstructured":"Ballester M, Bolonio M, Santamaria R, Castell JV, Ribes-Koninckx C, Bort R. Direct conversion of human fibroblast to hepatocytes using a single inducible polycistronic vector. Stem Cell Res Ther. 2019;10:317.","journal-title":"Stem Cell Res Ther"},{"key":"3311_CR10","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1038\/s41598-022-06184-w","volume":"12","author":"R Santamaria","year":"2022","unstructured":"Santamaria R, Ballester M, Garcia-Llorens G, Martinez F, Blazquez M, Ribes-Koninckx C, et al. Derivation of healthy hepatocyte-like cells from a female patient with ornithine transcarbamylase deficiency through X-inactivation selection. Sci Rep. 2022;12:2308.","journal-title":"Sci Rep"},{"key":"3311_CR11","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.3390\/jpm12071111","volume":"12","author":"G Garcia-Llorens","year":"2022","unstructured":"Garcia-Llorens G, Lopez-Navarro S, Jaijo T, Castell JV, Bort R. Modeling a novel variant of glycogenosis IXa Using a clonal inducible reprogramming system to generate \u201cdiseased\u201d hepatocytes for accurate diagnosis. J Pers Med. 2022;12:1111.","journal-title":"J Pers Med"},{"key":"3311_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.stem.2014.01.008","volume":"14","author":"Y Du","year":"2014","unstructured":"Du Y, Wang J, Jia J, Song N, Xiang C, Xu J, et al. Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming. Cell Stem Cell. 2014;14:394\u2013403.","journal-title":"Cell Stem Cell"},{"key":"3311_CR13","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s12072-013-9432-5","volume":"7","author":"T Kogiso","year":"2013","unstructured":"Kogiso T, Nagahara H, Otsuka M, Shiratori K, Dowdy SF. Transdifferentiation of human fibroblasts into hepatocyte-like cells by defined transcriptional factors. Hepatol Int. 2013;7:937\u201344.","journal-title":"Hepatol Int"},{"key":"3311_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41422-019-0196-x","volume":"29","author":"B Xie","year":"2019","unstructured":"Xie B, Sun D, Du Y, Jia J, Sun S, Xu J, et al. A two-step lineage reprogramming strategy to generate functionally competent human hepatocytes from fibroblasts. Cell Res. 2019;29:1\u201315.","journal-title":"Cell Res."},{"key":"3311_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13287-016-0349-5","volume":"7","author":"F Serrano","year":"2016","unstructured":"Serrano F, Garc\u00eda-Bravo M, Blazquez M, Torres J, Castell JV, Segovia JC, et al. Silencing of hepatic fate-conversion factors induce tumorigenesis in reprogrammed hepatic progenitor-like cells. Stem Cell Res Ther. 2016;7:96.","journal-title":"Stem Cell Res Ther"},{"key":"3311_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/clpt.2011.38","volume":"89","author":"H Inoue","year":"2011","unstructured":"Inoue H, Yamanaka S. The use of induced pluripotent stem cells in drug development. Clin Pharmacol Ther. 2011;89:655\u201361.","journal-title":"Clin Pharmacol Ther"},{"key":"3311_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.stem.2017.01.011","volume":"20","author":"MA Cayo","year":"2017","unstructured":"Cayo MA, Mallanna SK, Di Furio F, Jing R, Tolliver LB, Bures M, et al. A drug screen using human iPSC-derived hepatocyte-like cells reveals cardiac glycosides as a potential treatment for hypercholesterolemia. Cell Stem Cell. 2017;20:478-489.e5.","journal-title":"Cell Stem Cell"},{"key":"3311_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086372","volume":"9","author":"RL Gieseck 3rd","year":"2014","unstructured":"Gieseck RL 3rd, Hannan NR, Bort R, Hanley NA, Drake RA, Cameron GW, et al. Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture. PLoS ONE. 2014;9: e86372.","journal-title":"PLoS ONE"},{"key":"3311_CR19","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/ncb3438","volume":"18","author":"A Hayer","year":"2016","unstructured":"Hayer A, Shao L, Chung M, Joubert L-M, Yang HW, Tsai F-C, et al. Engulfed cadherin fingers are polarized junctional structures between collectively migrating endothelial cells. Nat Cell Biol. 2016;18:1311\u201323.","journal-title":"Nat Cell Biol"},{"key":"3311_CR20","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.stem.2008.08.014","volume":"3","author":"D Hockemeyer","year":"2008","unstructured":"Hockemeyer D, Soldner F, Cook EG, Gao Q, Mitalipova M, Jaenisch R. A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell. 2008;3:346\u201353.","journal-title":"Cell Stem Cell"},{"key":"3311_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/jcp.1041570225","volume":"157","author":"V Falanga","year":"1993","unstructured":"Falanga V, Martin TA, Takagi H, Kirsner RS, Helfman T, Pardes J, et al. Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts. J Cell Physiol. 1993;157:408\u201312.","journal-title":"J Cell Physiol"},{"key":"3311_CR22","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1038\/onc.2014.240","volume":"34","author":"V Marfil","year":"2015","unstructured":"Marfil V, Blazquez M, Serrano F, Castell JV, Bort R. Growth-promoting and tumourigenic activity of c-Myc is suppressed by Hhex. Oncogene. 2015;34:3011\u201322.","journal-title":"Oncogene"},{"key":"3311_CR23","doi-asserted-by":"publisher","first-page":"22119","DOI":"10.1038\/s41598-021-01652-1","volume":"11","author":"M Moreno-Torres","year":"2021","unstructured":"Moreno-Torres M, Garc\u00eda-Llorens G, Moro E, M\u00e9ndez R, Quint\u00e1s G, Castell JV. Factors that influence the quality of metabolomics data in in vitro cell toxicity studies: a systematic survey. Sci Rep. 2021;11:22119.","journal-title":"Sci Rep"},{"key":"3311_CR24","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3727\/096368908787236620","volume":"17","author":"MT Donato","year":"2008","unstructured":"Donato MT, Lahoz A, Montero S, Bonora A, Pareja E, Mir J, et al. Functional assessment of the quality of human hepatocyte preparations for cell transplantation. Cell Transplant. 2008;17:1211\u20139.","journal-title":"Cell Transplant"},{"key":"3311_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/toxsci\/kfs083","volume":"127","author":"L Tolosa","year":"2012","unstructured":"Tolosa L, Pinto S, Donato MT, Lahoz A, Castell JV, O\u2019Connor JE, et al. Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs. Toxicol Sci Off J Soc Toxicol. 2012;127:187\u201398.","journal-title":"Toxicol Sci Off J Soc Toxicol"},{"key":"3311_CR26","doi-asserted-by":"publisher","first-page":"R100","DOI":"10.1186\/gb-2006-7-10-r100","volume":"7","author":"AE Carpenter","year":"2006","unstructured":"Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, et al. Cell Profiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7:R100.","journal-title":"Genome Biol"},{"key":"3311_CR27","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.tiv.2007.03.022","volume":"21","author":"A Lahoz","year":"2007","unstructured":"Lahoz A, Donato MT, Picazo L, G\u00f3mez-Lech\u00f3n MJ, Castell JV. Determination of major human cytochrome P450s activities in 96-well plates using liquid chromatography tandem mass spectrometry. Toxicol Vitro Int J Publ Assoc BIBRA. 2007;21:1247\u201352.","journal-title":"Toxicol Vitro Int J Publ Assoc BIBRA"},{"key":"3311_CR28","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinforma Oxf Engl. 2014;30:923\u201330.","journal-title":"Bioinforma Oxf Engl"},{"key":"3311_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinforma Oxf Engl. 2013;29:15\u201321.","journal-title":"Bioinforma Oxf Engl"},{"key":"3311_CR30","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinforma Oxf Engl. 2009;25:1754\u201360.","journal-title":"Bioinforma Oxf Engl"},{"key":"3311_CR31","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"3311_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2105-10-11","volume":"10","author":"AJ Hackstadt","year":"2009","unstructured":"Hackstadt AJ, Hess AM. Filtering for increased power for microarray data analysis. BMC Bioinformatics. 2009;10:11.","journal-title":"BMC Bioinformatics"},{"key":"3311_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25:25\u20139.","journal-title":"Nat Genet"},{"key":"3311_CR34","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci"},{"key":"3311_CR35","doi-asserted-by":"publisher","first-page":"7810","DOI":"10.1039\/C5AN01638J","volume":"140","author":"J Kuligowski","year":"2015","unstructured":"Kuligowski J, S\u00e1nchez-Illana \u00c1, Sanju\u00e1n-Herr\u00e1ez D, Vento M, Quint\u00e1s G. Intra-batch effect correction in liquid chromatography-mass spectrometry using quality control samples and support vector regression (QC-SVRC). Analyst. 2015;140:7810\u20137.","journal-title":"Analyst"},{"key":"3311_CR36","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/nbt.2377","volume":"30","author":"MC Chambers","year":"2012","unstructured":"Chambers MC, Maclean B, Burke R, Amodei D, Ruderman DL, Neumann S, et al. A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol. 2012;30:918\u201320.","journal-title":"Nat Biotechnol"},{"key":"3311_CR37","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1021\/ac051437y","volume":"78","author":"CA Smith","year":"2006","unstructured":"Smith CA, Want EJ, O\u2019Maille G, Abagyan R, Siuzdak G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006;78:779\u201387.","journal-title":"Anal Chem"},{"key":"3311_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1126\/science.279.5349.349","volume":"279","author":"AG Bodnar","year":"1998","unstructured":"Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998;279:349\u201352.","journal-title":"Science"},{"key":"3311_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","volume":"572","author":"N Aizarani","year":"2019","unstructured":"Aizarani N, Saviano A, Mailly L, Durand S, Herman JS, et al. A human liver cell atlas reveals heterogeneity and epithelial progenitors. Nature. 2019;572:199\u2013204.","journal-title":"Nature"},{"key":"3311_CR40","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1089\/scd.2019.0064","volume":"28","author":"M Zabulica","year":"2019","unstructured":"Zabulica M, Srinivasan RC, Vosough M, Hammarstedt C, Wu T, Gramignoli R, et al. Guide to the assessment of mature liver gene expression in stem cell-derived hepatocytes. Stem Cells Dev. 2019;28:907\u201319.","journal-title":"Stem Cells Dev"},{"doi-asserted-by":"crossref","unstructured":"Gomez-Lechon MJ, Tolosa L, Castell JV, Donato MT. Mechanism-based selection of compounds for the development of innovative in vitro approaches to hepatotoxicity studies in the LIINTOP project. Toxicol Vitro Int J Publ Assoc BIBRA. Toxicol In Vitro; 2010;24. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20656008\/","key":"3311_CR41","DOI":"10.1016\/j.tiv.2010.07.018"},{"key":"3311_CR42","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jhep.2018.05.028","volume":"69","author":"C-P Segeritz","year":"2018","unstructured":"Segeritz C-P, Rashid ST, de Brito MC, Serra MP, Ordonez A, Morell CM, et al. hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in \u03b11-antitrypsin deficiency. J Hepatol. 2018;69:851\u201360.","journal-title":"J Hepatol"},{"key":"3311_CR43","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature10116","volume":"475","author":"P Huang","year":"2011","unstructured":"Huang P, He Z, Ji S, Sun H, Xiang D, Liu C, et al. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature. 2011;475:386\u20139.","journal-title":"Nature"},{"key":"3311_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1006\/excr.1993.1116","volume":"206","author":"M Miyazaki","year":"1993","unstructured":"Miyazaki M, Mihara K, Bai L, Kano Y, Tsuboi S, Endo A, et al. Immortalization of epithelial-like cells from human liver tissue with SV40 T-antigen gene. Exp Cell Res. 1993;206:27\u201335.","journal-title":"Exp Cell Res"},{"key":"3311_CR45","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1006\/excr.2000.4982","volume":"259","author":"KL MacKenzie","year":"2000","unstructured":"MacKenzie KL, Franco S, May C, Sadelain M, Moore MA. Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation. Exp Cell Res. 2000;259:336\u201350.","journal-title":"Exp Cell Res"},{"key":"3311_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00204-013-1123-4","volume":"88","author":"M Vinken","year":"2014","unstructured":"Vinken M, Maes M, Oliveira AG, Cogliati B, Marques PE, Menezes GB, et al. Primary hepatocytes and their cultures in liver apoptosis research. Arch Toxicol. 2014;88:199\u2013212.","journal-title":"Arch Toxicol"},{"key":"3311_CR47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.01.001","volume":"134","author":"A Astashkina","year":"2012","unstructured":"Astashkina A, Mann B, Grainger DW. A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. Pharmacol Ther. 2012;134:82\u2013106.","journal-title":"Pharmacol Ther"},{"issue":"6212","key":"3311_CR48","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1126\/science.opms.p1400090","volume":"346","author":"A Dove","year":"2014","unstructured":"Dove A. The art of culture: developing cell lines. Science. 2014;346(6212):1013\u20135. https:\/\/doi.org\/10.1126\/science.opms.p1400090.","journal-title":"Science"},{"key":"3311_CR49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/5056","volume":"21","author":"XR Jiang","year":"1999","unstructured":"Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet. 1999;21:111\u20134.","journal-title":"Nat Genet"},{"key":"3311_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/5063","volume":"21","author":"CP Morales","year":"1999","unstructured":"Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, et al. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet. 1999;21:115\u20138.","journal-title":"Nat Genet"},{"key":"3311_CR51","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1128\/MCB.19.3.2373","volume":"19","author":"H Vaziri","year":"1999","unstructured":"Vaziri H, Squire JA, Pandita TK, Bradley G, Kuba RM, Zhang H, et al. Analysis of genomic integrity and p53-dependent G1 checkpoint in telomerase-induced extended-life-span human fibroblasts. Mol Cell Biol. 1999;19:2373\u20139.","journal-title":"Mol Cell Biol"},{"key":"3311_CR52","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S0006-291X(03)01484-0","volume":"308","author":"C Mondello","year":"2003","unstructured":"Mondello C, Chiesa M, Rebuzzini P, Zongaro S, Verri A, Colombo T, et al. Karyotype instability and anchorage-independent growth in telomerase-immortalized fibroblasts from two centenarian individuals. Biochem Biophys Res Commun. 2003;308:914\u201321.","journal-title":"Biochem Biophys Res Commun"},{"key":"3311_CR53","doi-asserted-by":"publisher","first-page":"11411","DOI":"10.1158\/0008-5472.CAN-05-1140","volume":"65","author":"S Zongaro","year":"2005","unstructured":"Zongaro S, de Stanchina E, Colombo T, D\u2019Incalci M, Giulotto E, Mondello C. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line. Cancer Res. 2005;65:11411\u20138.","journal-title":"Cancer Res"},{"key":"3311_CR54","doi-asserted-by":"publisher","first-page":"12538","DOI":"10.1073\/pnas.1209979109","volume":"109","author":"M Kajiwara","year":"2012","unstructured":"Kajiwara M, Aoi T, Okita K, Takahashi R, Inoue H, Takayama N, et al. Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci. 2012;109:12538\u201343.","journal-title":"Proc Natl Acad Sci."},{"key":"3311_CR55","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1038\/s41467-020-16092-0","volume":"11","author":"P An","year":"2020","unstructured":"An P, Wei L-L, Zhao S, Sverdlov DY, Vaid KA, Miyamoto M, et al. Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis. Nat Commun. 2020;11:2362.","journal-title":"Nat Commun"},{"key":"3311_CR56","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3390\/metabo11100692","volume":"11","author":"AM Ara\u00fajo","year":"2021","unstructured":"Ara\u00fajo AM, Carvalho F, Guedes de Pinho P, Carvalho M. Toxicometabolomics: small molecules to answer big toxicological questions. Metabolites. 2021;11:692.","journal-title":"Metabolites"},{"key":"3311_CR57","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/metabo11090635","volume":"11","author":"KM da Silva","year":"2021","unstructured":"da Silva KM, Iturrospe E, Bars C, Knapen D, Van Cruchten S, Covaci A, et al. Mass spectrometry-based zebrafish toxicometabolomics: a review of analytical and data quality challenges. Metabolites. 2021;11:635.","journal-title":"Metabolites"},{"key":"3311_CR58","first-page":"497","volume":"54","author":"N Kaplowitz","year":"1981","unstructured":"Kaplowitz N. The importance and regulation of hepatic glutathione. Yale J Biol Med. 1981;54:497\u2013502.","journal-title":"Yale J Biol Med"},{"key":"3311_CR59","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/hep.21650","volume":"45","author":"JM Mato","year":"2007","unstructured":"Mato JM, Lu SC. Role of S-adenosyl-L-methionine in liver health and injury. Hepatol Baltim Md. 2007;45:1306\u201312.","journal-title":"Hepatol Baltim Md"},{"key":"3311_CR60","doi-asserted-by":"publisher","first-page":"e7511","DOI":"10.1371\/journal.pone.0007511","volume":"4","author":"G Tzur","year":"2009","unstructured":"Tzur G, Israel A, Levy A, Benjamin H, Meiri E, Shufaro Y, et al. Comprehensive gene and microRNA expression profiling reveals a role for microRNAs in human liver development. PLoS ONE. 2009;4:e7511.","journal-title":"PLoS ONE"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03311-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-023-03311-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03311-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T17:03:33Z","timestamp":1681837413000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-023-03311-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3311"],"URL":"https:\/\/doi.org\/10.1186\/s13287-023-03311-w","relation":{},"ISSN":["1757-6512"],"issn-type":[{"type":"electronic","value":"1757-6512"}],"subject":[],"published":{"date-parts":[[2023,4,18]]},"assertion":[{"value":"21 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The punch skin biopsy from a homozygous alphap-1-antitrypsin deficiency with Pi*ZZ genotype patient was freely donated for this study. Prior informed consent in writing was obtained and the study was revised and approved by the institutional ethical committee (title: Nuevas estrategias para generar hepatocitos humanos mediante reprogramaci\u00f3n cellular, approved Oct 5th 2015; number 2014-0672). Human liver samples were obtained from three different donors. Informed consent in writing was obtained and reflected in approval by the institutional ethical committee (title: Diferenciaci\u00f3n de c\u00e9lulas som\u00e1ticas y progenitoras en c\u00e9lulas de linaje hep\u00e1tico, y su uso con fines diagn\u00f3sticos y terap\u00e9uticos en hepatotoxicidad idiosincr\u00e1sica por medicamentos, approved Dec 22nd 2021; number 2021-771-1). The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not aplicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}